Safety of erythrocyte encapsulated asparaginase in patients above 55 years of age newly diagnosed with acute lymphoblastic leukaemia.
Phase of Trial: Phase I
Latest Information Update: 14 Jul 2014
At a glance
- Drugs ERY-ASP (Primary)
- Indications Acute lymphoblastic leukaemia
- Focus Adverse reactions
- 14 Jul 2014 New trial record